⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ACLX News
Arcellx, Inc. Common Stock
Immunotherapy Delivers Across Tumor Types as Oncology Market Eyes $750 Billion
prnewswire.com
MRK
ACLX
LLY
ONCY
GILD
Halper Sadeh LLC is Investigating Whether ACLX, EHAB, VRE are Obtaining Fair Deals for their Shareholders
globenewswire.com
VRE
ACLX
EHAB
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger—KW, MASI, ACLX, and VRE
globenewswire.com
KW
MASI
ACLX
VRE
Arcellx Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Arcellx, Inc. - ACLX
businesswire.com
ACLX
GILD
Are ACLX, VRE, UHG, EHAB Obtaining Fair Deals for their Shareholders?
prnewswire.com
VRE
ACLX
UHG
EHAB
Form 8-K
sec.gov
ACLX
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Arcellx, Inc. (NASDAQ: ACLX)
prnewswire.com
ACLX
Shareholder Alert: The Ademi Firm investigates whether Arcellx Inc. is obtaining a Fair Price for its Public Shareholders
prnewswire.com
ACLX
Shareholder Alert: The Ademi Firm investigates whether Arcellx Inc. is obtaining a Fair Price for its Public Shareholders
prnewswire.com
ACLX
Biotech Breakthroughs, Big Buyouts, Immunotherapy Momentum, and a Media Megamerger
globenewswire.com
ACLX
IBRX
GETY